Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity: Synthesis and biological evaluation of pyridine hydrazide derivatives

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 2, 2005, Pages 81-85

  Galiano, Silvia ^a   Erviti, Oihana ^a   Pérez, Silvia ^a   Moreno, Antonio ^a   Juanenea, Laura ^a   Aldana, Ignacio ^a   Monge, Antonio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Neuropeptide Y; Neuropeptide Y Y5 antagonists; Obesity; Pyridine hydrazide derivatives, neuropeptide Y Y5 receptor binding studies, synthesis

Indexed keywords

ANTIOBESITY AGENT; HYDRAZIDE; N [4 [N' (PYRIDINE 3 CARBONYL)HYDRAZINOCARBONYL]CYCLOHEXYLMETHYL] 2,4 DICHLOROBENZENESULFONAMIDE; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR ANTAGONIST; PYRIDINE DERIVATIVE; RECEPTOR BLOCKING AGENT; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON TRANSPORT; HUMAN; IC 50; OBESITY; RECEPTOR BINDING;

EID: 14744267424     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296827     Document Type: Article

References (22)

1. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3-5 June, 1997. WHO, Geneva (1998)
2. Bray, G. A., Tartaglia, L. A., Medicinal strategies in the treatment of obesity. Nature 404, 672 (2000)
3. Bray, G. A., Greenway, F. L., Current and Potential Drugs for treatment of Obesity. Endocr. Rev. 20, 805 (1999)
4. Blevins, J. E., Schwartz, M. W., Baskin, D. G., Peptide signals regulating food intake and energy homeostasis. Can. J. Physiol. Pharm. 80, 396 (2002)
5. Kalra, S. P., Dube, M. G., Pu, S. Y. et al., Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20, 68 (1999)
6. Erickson, J. C., Hollopeter, G., Palmiter, R. D., Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274, 1704 (1996)
7. Kask, A., Schioth, H. B., Harro, J., et al., Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists. Can. J. Physiol. Pharm. 78, 143 (2000)
8. Clark, J. T., Kalra, P. S., Crowley, W. R. et al., Neuropeptide Y and Human Pancreatic Polypeptide Stimulate Feeding Behavior in Rats. Endocrinology 115, 427 (1984)
9. Tatemoto, K., Carlquist, M., Mutt, V., Neuropeptide Y: A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296, 659 (1982)
10. Stanley, B. G., Leibowitz, S. F., Neuropeptide Y: Stimulation of Feeding and Drinking by Injection into the Paraventricular Nucleus. Life Sci. 35, 2635 (1984)
11. Blomqvist, A. G., Herzog, H., Y-receptor subtypes - how many more? Trends Neurosci. 20, 294 (1997)
12. Naveilhan, P., Neveu, I., Arenas, E. et al., Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 87, 289 (1998)
13. Parker, R. M., Herzog, H., Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431 (1999)
14. Inui, A., Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol. Sci. 20, 43 (1999)
15. Kanatani, A., Mashiko, S., Murai, N., Role of Y1 receptor in the regulation of neuropeptide Y-mediated feeding regulation: comparison of wild-type, Y1 receptor deficient and Y5 receptor deficient mice. Endocrinology 141, 1011 (2000)
16. Rüeger, H., Schmidlin, T, Rigollier, P. et al., Preparation of 2-aminoquinazolines as neuropeptide Y subtype Y5 receptor antagonists. PCT Int. Appl. WO 9720823, Novartis, Basel (1997)
17. Rüeger, H., Schmidlin, T., Rigollier, P. et al., Quinazoline-2,4-diazirines as NPY receptor antagonists. PCT Int. Appl. WO 9720822, Novartis, Basel (1997)
18. Islam, I., Dhanoa, D. S., Finn, J. M. et al., Preparation of aryl sulfonamide and sulfamide derivatives which bind to selectively to the human Y5 receptor. PCT Int. Appl. WO 97/ 19682, Synaptic Pharmaceutical, Paramus, NJ, USA (1997)
19. Youngman, M. A., McNally, J. J., Lovenberg, T. W. et al., (-Subtituted N-(Sulfonamido)alkyl-β-aminotetralins: Potent and selective Neuropeptide Y Y5 Receptor Antagonists. J. Med. Chem. 43, 346 (2000)
20. Hofbauer, K. G., Schaffhauser, A. O., Batzl-Hartmann, C. et al., Antisense oligonucleotides targeted against the NPY Y5 receptor and selective Y5 receptor antagonist inhibit food intake in rodents. Regul. Pept. 71, 211 (1997)
21. Sheehan, J., Preston, J., Cruickshank, P. A., A rapid synthesis of oligopeptide Derivatives without Isolation of Intermediate. J. Am. Chem. Soc. 87, 2492 (1965)
22. Duhault, J., Boulanger, M., Chamorro, S. et al., Food intake regulation in rodents: Y5 or Y1 NPY receptors or both? Can. J. Biochem. Physiol. 78, 173 (2000).